Drug intelligence / Profile preview

opuntiol

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Opuntiol is a natural pyrone derivative, specifically 4-hydroxy-6-(hydroxymethyl)-2H-pyran-2-one, isolated from plants of the *Opuntia* genus, commonly known as prickly pear cactus. It has been identified as a bioactive compound with significant anti-inflammatory and potential anti-cancer properties. In preclinical studies, opuntiol has demonstrated the ability to inhibit the growth of human glioblastoma multiforme (GBM) cells, such as the U87 cell line, by inducing apoptosis. Its mechanism of action involves the upregulation of active Caspase 3 expression, which leads to characteristic apoptotic changes including nuclear condensation and DNA fragmentation. While it shows promise as a therapeutic agent for aggressive and apoptosis-resistant tumors, it is currently in the early stages of research and has not yet progressed to clinical trials.

Other names
4-hydroxy-6-(hydroxymethyl)-2H-pyran-2-one6-hydroxymethyl-4-hydroxy-2-pyrone
02

Targets

CASP3 (Caspase-3)

Beyond the preview

Go deeper on opuntiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on opuntiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call